Emerging applications of clinical ultrasonography.

In this work, we introduce the numerous emerging areas and frontiers in the use of point-of-care ultrasonography. Of these, we review the following three: 1) the use of clinical ultrasonography in infectious and tropical diseases (we address its usefulness in the diagnosis and follow-up of the main syndromes, in tropical diseases, and in areas with scarce resources); 2) the usefulness of clinical ultrasonography in the assessment of response to volume infusion in severely ill patients (we review basic concepts and the main static and dynamic variables used for this evaluation); and 3) the use of clinical ultrasonography in the assessment of muscle mass in elderly patients with primary sarcopenia (we review the main muscles and measurements used for it).

Aplicaciones emergentes de la ecografía clínica / Emerging applications of clinical ultrasonography

En el documento actual introduciremos las áreas más emergentes y frontera del uso de la ecografía clínica a la cabecera del paciente, que son numerosas. De entre todas ellas se revisarán 3: 1) la ecografía clínica en las enfermedades infecciosas y patología tropical (se abordará su utilidad en el diagnóstico y seguimiento de los principales síndromes, así como los usos para patología tropical y en áreas con escasos recursos); 2) la utilidad de la ecografía clínica para la evaluación de la respuesta a la infusión de volumen en pacientes graves (se revisarán conceptos básicos, así como las principales variables estáticas y dinámicas utilizadas para realizar esta evaluación); y por último, 3) se abordará la utilización de la ecografía clínica para la valoración de la masa muscular en la sarcopenia primaria de las personas ancianas (se repasarán los principales músculos y medidas que se utilizan para ello) (AU)

In this work, we introduce the numerous emerging areas and frontiers in the use of point-of-care ultrasonography. Of these, we review the following three: 1) the use of clinical ultrasonography in infectious and tropical diseases (we address its usefulness in the diagnosis and follow-up of the main syndromes, in tropical diseases, and in areas with scarce resources); 2) the usefulness of clinical ultrasonography in the assessment of response to volume infusion in severely ill patients (we review basic concepts and the main static and dynamic variables used for this evaluation); and 3) the use of clinical ultrasonography in the assessment of muscle mass in elderly patients with primary sarcopenia (we review the main muscles and measurements used for it) (AU)

Emerging applications of clinical ultrasonography. / Aplicaciones emergentes de la ecografía clínica.

In the current document, we introduce the numerous emerging areas and frontiers in the use of point-of-care clinical ultrasonography. Of these, we review the following 3: 1) the use of clinical ultrasonography in infectious and tropical diseases (we address it's usefulness in the diagnosis and follow-up of the main syndromes, tropical diseases and in areas with scarce resources); 2) the usefulness of clinical ultrasonography in the assessment of response to volume infusion in severely ill patients (we review basic concepts and the main static and dynamic variables employed for this evaluation); and 3) the use of clinical ultrasonography in the assessment of muscle mass in elderly patients with primary sarcopenia (we review the main muscles and measurements employed for them it.

Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.

OBJECTIVES: International health agencies have promoted nontargeted universal (opt-out) HIV screening tests in different settings, including emergency departments (EDs). We performed a systematic review and meta-analysis to assess the testing uptake of strategies (opt-in targeted, opt-in nontargeted and opt-out) to detect new cases of HIV infection in EDs. METHODS: We searched the Pubmed and Embase databases, from 1984 to April 2015, for opt-in and opt-out HIV diagnostic strategies used in EDs. Randomized controlled or quasi experimental studies were included. We assessed the percentage of positive individuals tested for HIV infection in each programme (opt-in and opt-out strategies). The mean percentage was estimated by combining studies in a random-effect meta-analysis. The percentages of individuals tested in the programmes were compared in a random-effect meta-regression model. Data were analysed using stata version 12. Quality assessments were performed using the Newcastle-Ottawa Scale. RESULTS: Of the 90 papers identified, 28 were eligible for inclusion. Eight trials used opt-out, 18 trials used opt-in, and two trials used both to detect new cases of HIV infection. The test was accepted and taken by 75 155 of 172 237 patients (44%) in the opt-out strategy, and 73 581 of 382 992 patients (19%) in the opt-in strategy. The prevalence of HIV infection detected by the opt-out strategy was 0.40% (373 cases), that detected by the opt-in nontargeted strategy was 0.52% (419 cases), and that detected by the opt-in targeted strategy was 1.06% (52 cases). CONCLUSIONS: In this meta-analysis, the testing uptake of the opt-out strategy was not different from that of the opt-in strategy to detect new cases of HIV infection in EDs.